MG
LABU icon

Mather Group’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Mather Group’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86K Buy
+13
New +$2.49K ﹤0.01% 1659

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return

Mather Group's LABU Position: Q2 2026 in Review

Mather Group opened a new position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2026: 13 shares worth $3.86K. The stake represents ﹤0.01% of the portfolio and ranks #1659 among its holdings.

36 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • Mather Group held 13 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $3.86K as of Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF was a new Mather Group position in Q2 2026.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1659 holding.
  • 36 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.